Association between the tumour necrosis factor-α−308G/A polymorphism and chronic obstructive pulmonary disease: An update.

Previous studies have suggested that the −308A allele in the tumour necrosis factor-α (TNF-α) gene promoter (rs1800629) may be a potential risk factor for COPD. However, more recent findings have been inconsistent. In the present study, a meta-analysis was performed to assess the association between the TNF-α−308G/A single nucleotide polymorphism (SNP) and the risk of COPD. Published studies were retrieved from PubMed, EMBASE and other databases. All studies assessing the association between the TNF-α−308G/A SNP and the risk of COPD were assessed. Pooled ORs with 95% CIs were calculated. In the 36 studies that met the inclusion criteria, 4975 patients and 6518 control subjects had been genotyped. The overall results showed that the association between the TNF-α−308G/A SNP and the risk of COPD was statistically significant for Asians (OR = 2.36, 95% CI: 1.84-3.02, P < 0.0001) but not for Caucasians (OR = 1.07, 95% CI: 0.91-1.25, P = 0.438). As smoking is one of the most important risk factors for COPD, a second meta-analysis that included only smokers (3018 patients and 2749 control subjects) was performed. This analysis confirmed that the association between the TNF-α−308G/A SNP and COPD was statistically significant for Asians (OR = 1.72, 95% CI: 1.14-2.61, P = 0.011) but not for Caucasians (OR = 1.16, 95% CI: 0.86-1.56, P = 0.33). This meta-analysis suggests that the TNF-α−308A genotype is associated with an increased risk of COPD in Asian but not Caucasian populations. Further studies are necessary to evaluate the relationship between TNF-α polymorphisms and the risk of COPD. An updated meta-analysis shows that the TNF-α−308A genotype is associated with an increased risk for development of COPD in Asian but not Caucasian populations. [ABSTRACT FROM AUTHOR]